TLR2+ cells are not targeted or killed. HP-NAP secreted by the CAR T cells engages TLR2 on innate immune cells to activate them; cytotoxicity is directed against CD20+ cells via CAR T–mediated killing, with additional bystander effects from activated innate cells.